The Role of Laparoscopic Metabolic Surgery in Treating Type-2 Diabetes: An Evidence Update

Title : The Role of Laparoscopic Metabolic Surgery in Treating Type-2 Diabetes: An Evidence Update

Abstract:

The laparoscopic approach to gastrointestinal cancer resections offers advantages in terms of postoperative hospital stay, return of bowel function and intensive care and hospital stays. Though laparoscopic pancreatic resections are technically demanding, they are gaining increasing acceptance in specialised units. We appraise case-matched comparative studies, randomised studies and meta-analyses that compared laparoscopic with open pancreatic resections (pancreaticoduodenectomy, distal pancreatectomy) and present an evidence-based update to guide practice.

The data suggest that whilst laparoscopic resections in experienced hands require significantly longer operating time than open resections, they are associated with benefits, particularly significant reductions in intensive care and hospital stay and more rapid functional recovery. The laparoscopic approach to pancreatic resections is becoming the gold standard approach in selected patients and in experienced hands within high volume units.

Biography:

Dr. Basil Ammori graduated with MB ChB degree from Baghdad University, Iraq in 1986. He undertook his surgical training in the UK, completed an MD degree from Leeds University and his CCST in 2000, and became a Consultant Laparoscopic, Bariatric and Hepatopancreatobiliary Surgeon in Manchester, UK 2000-2017. He joined King Hussein Cancer Center in Jordan as a Gastrointestinal Surgeon in November 2017. He was granted a Hunterian Professorship by the Royal College of Surgeons of England in 2000 and appointed as Honorary Professor of Surgery at Manchester University, UK in 2011. He has over 170 publications in peer-reviewed medical journals.